neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2003
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Female (MeSH)
- Gene Expression Regulation, Neoplastic (MeSH)
- Genetic Markers (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Ovariectomy (MeSH)
- Premenopause (MeSH)
- Prognosis (MeSH)
- Receptor, ErbB-2 (MeSH)
- Tamoxifen (MeSH)
- Treatment Outcome (MeSH)
published in
- Journal of Clinical Oncology Journal